INTS
Intensity Therapeutics, Inc. Common stock
NASDAQ: INTS · HEALTHCARE · BIOTECHNOLOGY
$5.21
+0.06% today
Updated 2026-05-06
Market cap
$13.80M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.56
Dividend yield
—
52W range
$5 – $44
Volume
0.0M
Intensity Therapeutics, Inc. Common stock (INTS) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-50.9%
Last 4 quarters
Revenue YoY growth
-208.3%
Most recent quarter
EPS YoY growth
-3.3%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-13.8%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-14.3%
2026-03-12
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $-1.21 | -2317.2% | $7.91 | $6.78 | -14.3% |
| 2025-11-07 | $-0.06 | +0.0% | $0.49 | $0.42 | -13.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.05 | $-1.21 | -2317.2% | $-26000.00 | -208.3% |
| 2025-09-30 | $-0.06 | $-0.06 | +0.0% | — | — |
| 2025-06-30 | $-0.16 | $-0.13 | +18.8% | — | — |
| 2025-03-31 | $-0.18 | $-0.22 | -22.2% | — | — |
| 2024-12-31 | $-0.22 | $-1.17 | -431.8% | $24000.00 | -91.5% |
| 2024-09-30 | $-0.31 | $-0.25 | +18.0% | — | — |
| 2024-06-30 | $-0.32 | $-0.36 | -12.5% | — | — |
| 2024-03-31 | $-0.34 | $-0.34 | +0.0% | — | — |
| 2023-12-31 | $-0.18 | $-0.23 | -28.6% | $282216.00 | — |
| 2023-09-30 | $-0.09 | $-0.17 | -88.9% | — | — |
| 2023-06-30 | $-0.40 | $-1.43 | -257.5% | — | — |
| 2023-03-31 | $-0.39 | $-0.39 | +0.0% | — | — |
Frequently asked questions
Has Intensity Therapeutics, Inc. Common stock beaten earnings estimates?
Intensity Therapeutics, Inc. Common stock has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -50.9% over the last 4 quarters.
How does INTS stock react to earnings?
INTS stock has moved an average of -13.8% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Intensity Therapeutics, Inc. Common stock's revenue growth rate?
Intensity Therapeutics, Inc. Common stock reported year-over-year revenue growth of -208.3% in its most recent quarter, with EPS growing -3.3% year-over-year.